XML 63 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2022
Mar. 31, 2016
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Related Party Transaction [Line Items]                
Revenue from related parties     $ 225,971 $ 784,395 $ 340,914 $ 983,469    
Collaborative agreement, amended amount             $ 13,600,000  
Research and development expenses     $ 23,743,970 56,464,885 $ 53,920,481 112,443,496    
Plumbline Life Sciences                
Related Party Transaction [Line Items]                
Investment owned (in shares)     597,808   597,808      
Non-controlling interest     18.70%   18.70%      
Revenue under collaborative research and development arrangements with affiliated entities                
Related Party Transaction [Line Items]                
Revenue from related parties     $ 0 6,000 $ 0 15,000    
Director                
Related Party Transaction [Line Items]                
Expenses to reimburse   $ 3,100,000            
Term   5 years            
Contra-research and development expense     179,000 3,900,000 390,000 5,400,000    
The Wistar Institute                
Related Party Transaction [Line Items]                
Accounts receivable $ 9,900,000   5,000,000   5,000,000      
Awarded amount 1,200,000             $ 10,700,000
Awarded option amount 5,400,000           $ 1,600,000  
Research and development expenses     510,000 $ 444,000 932,000 $ 626,000    
Accounts payable and accrued liabilities, current 1,200,000   1,700,000   1,700,000      
Deferred grant funding, from affiliate     44,000   44,000      
Prepaid balance     12,000   12,000      
Plumbline Life Sciences                
Related Party Transaction [Line Items]                
Accounts receivable $ 59,000   $ 59,000   $ 59,000